TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
VCYT

Veracyte Inc

Healthcare · Diagnostics & Research

43.80$ +1.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 150 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VCYT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
90 98 97 114 116 119 114 130 132 141 139 150 562
28 29 34 37 37 40 35 40 41 36 38 42 157
62 69 62 78 79 79 80 90 91 105 101 109 405
13 19 16 16 18 19 18 16 16 21 27 29 93
16 41 43 47 40 47 52 14 43 1.4 24 27 96
94 104 67 73 67 75 77 95 68 79 77 86 309
-32 -36 -4.7 4.6 12 4.2 2.9 -5.3 23 26 24 23 96
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
-30 -30 -1.9 7.4 17 3.4 7.4 1.3 19 41 30 19 109
-0.2 -2.2 0.0 1.6 1.7 -1.7 0.4 2.2 -0.2 -0.5 1.3 -6.0 -5.5
-30 -28 -1.9 5.7 15 5.1 7.0 -1.0 19 41 29 25 114
-22 -24 1.9 13 23 9.7 6.5 6.7 24 46 35 24 130

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?